Investment Planning and Prospect Forecast Report of China's In Vitro Diagnostics Industry from 2023 to 2028

In vitro diagnostic IVD(in-VitroDiagnostics) is a product and service that obtains clinical information from human specimens outside the human body to determine the body's function and disease. In vitro diagnosis, known as "doctor's eye", is an important carrier of modern laboratory medicine, which provides most of the decision-making information of clinical diagnosis, and is increasingly becoming an important part of human disease prevention, diagnosis and treatment.

In the 1980 s, the first batch of in vitro diagnostic product manufacturers appeared in China, which opened the prelude to the in vitro diagnostic industry. In the early stage of development, there was a big gap between domestic technology level and product quality and foreign countries, mainly to learn and imitate foreign products. After 30 years of development and growth, it has the conditions for large-scale industrial development and is in a critical period of rapid development.

China's in vitro diagnostics market grew from $45 billion in 2016 to $124.3 billion in 2021, accounting for 12.2 percent of the medical device market in 2016 to 15.1 percent in 2019. The proportion occupied is getting heavier and heavier. Driving factors such as technological innovation, aging population, increasing insurance coverage and expenditure, and income growth are driving the growth of China's in vitro diagnostics industry.

On August 31, 2021, the State Administration of Market Supervision and Administration promulgated the Administrative Measures for the Registration and Filing of In Vitro Diagnostic Reagents, which will come into effect on October 1, 2021, with the aim of regulating the registration and filing of in vitro diagnostic reagents and ensuring the safety, effectiveness and controllable quality of in vitro diagnostic reagents. On September 27, 2021, in order to guide the clinical trials of in vitro diagnostic reagents, the State Food and Drug Administration issued the Technical Guidelines for Clinical Trials of In Vitro Diagnostic Reagents, which will be implemented from the date of issuance, and the Technical Guidelines for Clinical Trials of In Vitro Diagnostic Reagents issued by the former State Food and Drug Administration shall be abolished. On October 29, 2021, the State Drug Administration issued an announcement on the Rules for the Classification of In Vitro Diagnostic Reagents (No. 129 of 2021) to further standardize the classification and management of in vitro diagnostic reagents.

In the first half of 2022, the domestic IVD industry disclosed a total of 50 investment and financing events, with a cumulative amount of more than 7 billion yuan. In terms of segments, financing events are concentrated in the molecular diagnostic track, accounting for more than 50%, followed by the mass spectrometry track, which is the most concerned by investors.

The Report on Investment Planning and Prospects for China's In Vitro Diagnostics Industry from 2023 to 2028, published by the Rui Guan Industry Research Institute, consists of 15 chapters. Firstly, the basic situation of the in vitro diagnostics industry, the development environment and the impact of the new coronary pneumonia epidemic on the development of the in vitro diagnostics industry are introduced, followed by an in-depth analysis of in vitro diagnostics, and then an analysis of the in vitro diagnostics sub-industry is introduced, followed by an introduction to the layout and operation of key enterprises in the field of in vitro diagnostics at home and abroad. Finally, the investment potential and future development prospects and trends of the in vitro diagnostic industry are scientifically predicted.

The data in this research report mainly comes from the National Bureau of Statistics, the National Health Commission, the National Drug Administration, the Industrial Research Institute, the Market Research Center of the Industrial Research Institute, and key publications at home and abroad. The data is authoritative, detailed and rich. At the same time, through professional Analysis and prediction models, scientifically predict the core development indicators of the industry. If you or your organization want to have a systematic in-depth understanding of in vitro diagnostics, or want to invest in in vitro diagnostics related markets, this report will be an indispensable and important reference tool for you.